Nano Cap New Millennium Growth Fund L P Invests $1.22 Million in SPDR S&P Biotech ETF $XBI

Nano Cap New Millennium Growth Fund L P bought a new position in SPDR S&P Biotech ETF (NYSEARCA:XBI) during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm bought 10,000 shares of the exchange traded fund’s stock, valued at approximately $1,219,000.

Several other institutional investors have also made changes to their positions in XBI. AQR Capital Management LLC increased its position in shares of SPDR S&P Biotech ETF by 77.1% in the first quarter. AQR Capital Management LLC now owns 4,978 shares of the exchange traded fund’s stock worth $404,000 after acquiring an additional 2,167 shares in the last quarter. Marshall Wace LLP increased its position in shares of SPDR S&P Biotech ETF by 102.3% in the second quarter. Marshall Wace LLP now owns 4,023 shares of the exchange traded fund’s stock worth $334,000 after acquiring an additional 179,029 shares in the last quarter. The Manufacturers Life Insurance Company purchased a new position in shares of SPDR S&P Biotech ETF in the second quarter worth approximately $260,000. Ameriprise Financial Inc. increased its position in shares of SPDR S&P Biotech ETF by 123.0% in the second quarter. Ameriprise Financial Inc. now owns 872,796 shares of the exchange traded fund’s stock worth $72,542,000 after acquiring an additional 481,408 shares in the last quarter. Finally, EP Wealth Advisors LLC increased its position in shares of SPDR S&P Biotech ETF by 3.7% in the second quarter. EP Wealth Advisors LLC now owns 5,379 shares of the exchange traded fund’s stock worth $446,000 after acquiring an additional 193 shares in the last quarter.

SPDR S&P Biotech ETF Price Performance

SPDR S&P Biotech ETF stock opened at $132.78 on Friday. The firm’s 50 day simple moving average is $129.72 and its 200-day simple moving average is $125.00. The company has a market cap of $8.47 billion, a P/E ratio of 11.47 and a beta of 0.85. SPDR S&P Biotech ETF has a fifty-two week low of $78.00 and a fifty-two week high of $139.19.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.